Publications by authors named "J McVey"

Kenneth Keown, MD, was a forward-thinking anesthesiologist who developed techniques to allow the safe practice of cardiac anesthesia and opened the door for the future development of more complex intracardiac surgical procedures. His early successful protocols for cardiac anesthesiology and his wide-reaching education of others on these methods earned him the designation of "the grand old man of anesthesia for inside-the-heart surgery" at a young age. His contributions also extended to groundbreaking research in hypothermia, lidocaine uses as an antiarrhythmic, and advocacy for anesthesiology as a specialty.

View Article and Find Full Text PDF
Article Synopsis
  • Post-liver transplant (LT) patients require immunosuppression to avoid organ rejection, but this increases the risk of tumor recurrence, particularly for patients with hepatocellular carcinoma (HCC).
  • This study analyzed data from 1,406 HCC patients who underwent LT to assess the impact of varying levels of tacrolimus (FK) immunosuppression on cancer recurrence, finding that FK levels measured two weeks post-transplant were significantly associated with recurrence risk.
  • Results indicate that personalized immunosuppression strategies should consider the timing and individual patient's risk factors (like tumor characteristics) to optimize outcomes after LT.
View Article and Find Full Text PDF

Background: The intimal hyperplasia (IH) and vascular remodelling that follows endovascular injury, for instance after post-angioplasty re-stenosis, results in downstream ischaemia and progressive end organ damage. Interferon gamma (IFNγ) is known to play a critical role in this process. In mouse models we have previously shown that fibrocytes expressing tissue factor (TF) are recruited early to the site of injury.

View Article and Find Full Text PDF

Background & Aims: Continuous risk-stratification of candidates and urgency-based prioritization have been utilized for liver transplantation (LT) in patients with non-hepatocellular carcinoma (HCC) in the United States. Instead, for patients with HCC, a dichotomous criterion with exception points is still used. This study evaluated the utility of the hazard associated with LT for HCC (HALT-HCC), an oncological continuous risk score, to stratify waitlist dropout and post-LT outcomes.

View Article and Find Full Text PDF